2019 annual financial data
Chemomab Therapeutics 2019 Net income growth
Direct answer
Net income growth was 104.26%.
Operating income was 27,124,000 USD and net income was 27,124,000 USD.
Operating cash flow was -16,511,252 USD.
Get free Chemomab Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- 27,124,000 USD
- Net income
- 27,124,000 USD
- Operating cash flow
- -16,511,252 USD